Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00153127 · ClinicalTrials.gov registry record · Phase 4
Comparison of PolyethyleneGlycol and Placebo for Relief of Constipation From Constipating Medications
A Phase 4 study of Constipation, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 4
- Study locations
NCT00153127: Completed Phase 4 study of Constipation, sponsored by Braintree Laboratories.
NCT00153127 is a Phase 4 study of Constipation that has completed, run by Braintree Laboratories. The registered enrollment target is 100 participants, below the 204-participant average among 54 other Constipation trials with a reported enrollment target (51% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00153127, a Phase 4 study of Constipation, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to assess treatment responses comparing a newly FDA-approved PEG laxative versus placebo.
Conditions Studied
Interventions
- DRUG polyethyleneglycol3350
Study Locations (4)
Alabama
- - Mobile
Florida
- - St. Petersburg
Missouri
- - St Louis
North Carolina
- - Raleigh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2001-11 |
| Phase | Phase 4 |
What the finished NCT00153127 record still lists
NCT00153127 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 204-participant average among 54 other Constipation trials with a reported enrollment target (51% lower).
The record links to 1 condition, with Constipation appearing as the primary indexed condition, and to 1 intervention - of which polyethyleneglycol3350 is the first listed.
NCT00153127 reports a single indexed study location in Alabama, Florida, Missouri.
Frequently Asked Questions
What is clinical trial NCT00153127 about?
NCT00153127 is a clinical study titled "Comparison of PolyethyleneGlycol and Placebo for Relief of Constipation From Constipating Medications". The purpose of this study is to assess treatment responses comparing a newly FDA-approved PEG laxative versus placebo.
What is the current status of trial NCT00153127?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2001-11.
What conditions does trial NCT00153127 study?
This clinical trial studies the following conditions: Constipation.
What interventions are being tested in trial NCT00153127?
The interventions under investigation include: polyethyleneglycol3350 (DRUG).
Who is sponsoring clinical trial NCT00153127?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00153127 being conducted?
This trial has 4 study locations across Alabama, Florida, Missouri, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Constipation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00153127's enrollment target sits among peer trials
100 17th of 54 higher than 35 of 54 other Constipation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Constipation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pre-operative Polyethylene Glycol 3350 for Minimally Invasive Urogynecologic Surgery
RECRUITING · Phase 4
-
Evaluation of Fecal Microbiome Changes After Antegrade Continence Enema Placement and Initiation of Bowel Flush Regimen
RECRUITING · Phase 4
-
Preop Laxatives in Robotic Urologic Surgery
RECRUITING · Phase 4
-
Extended Use of Polyethyleneglycol3350 Laxative in Constipated Patients
COMPLETED · Phase 4
-
An Open Label Study of Chronic Polyethyleneglycol3350 Use in Constipated Patients
COMPLETED · Phase 4
-
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia